Joao P. De Aquino, MD

• Brian Fuehrlein
• David Moore
• David Ross
• Deepak Cyril Dsouza
• Elina A. Stefanovics
• John Cahill
• Jose Cortes-Briones
• José Flores
• Kirsten Wilkins
• Mehmet Sofuoglu
• Mohamed Sherif
• Mohini Ranganathan
• Rajiv Radhakrishnan
• Robert Rosenheck
• Suprit Parida
• Tanner Bommersbach
• Thomas Hickey
• Victor J. Avila-Quintero

Buprenorphine; Cannabinoids; Cannabis; Cognition; Methadone; Opioid-Related Disorders; Pain; Pain Measurement; Reward; Sensory Thresholds; Cognitive Science; Craving; Attentional Bias; Addiction Medicine

• Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development.De Aquino JP, Flores JM, Avila-Quintero VJ, Compton P, Sofuoglu M. Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development. Addiction Biology 2021, 26:e12964.
• The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.De Aquino JP, Parida S, Sofuoglu M. The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder. Clinical Drug Investigation 2021, 41:425-436.
• Opioid-Induced Analgesia Among Persons with Opioid Use Disorder Receiving Methadone or Buprenorphine: A Systematic Review of Experimental Pain StudiesJoao P. De Aquino, Suprit Parida, Victor J. Avila-Quintero, Jose Flores, R.N. Peggy Compton, Thomas Hickey, Oscar Gómez, Mehmet Sofuoglu. Opioid-Induced Analgesia Among Persons with Opioid Use Disorder Receiving Methadone or Buprenorphine: A Systematic Review of Experimental Pain Studies. Drug and Alcohol Dependence. 109097. ISSN 0376-8716.
• Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study.De Aquino JP, Sofuoglu M, Stefanovics EA, Rosenheck RA. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study. The American Journal Of Drug And Alcohol Abuse 2020, 46:812-822.
• Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.De Aquino JP, Sofuoglu M, Stefanovics E, Rosenheck R. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only. The American Journal Of Drug And Alcohol Abuse 2019, 45:527-537.
• Perpetual Hunger: The Neurobiological Consequences of Long-Term Opioid Use.Bommersbach T, Ross DA, De Aquino JP. Perpetual Hunger: The Neurobiological Consequences of Long-Term Opioid Use. Biological Psychiatry 2020, 87:e1-e3.
• Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?De Aquino JP, Bahji A, D'Souza DC (2021) Letter to the Editor: Cannabis as a solution to the opioid crisis: Is the cart before the horse again?, Cannabis and Cannabinoid Research X:X, 1–3, DOI: 10.1089/can.2021.0155.
• Cannabinoids and Pain: Weeding Out Undesired Effects With a Novel Approach to Analgesia.De Aquino JP, Ross DA. Cannabinoids and Pain: Weeding Out Undesired Effects With a Novel Approach to Analgesia. Biological Psychiatry 2018, 84:e67-e69.
• The Psychiatric Consequences of Cannabinoids.De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. The Psychiatric Consequences of Cannabinoids. Clinical Therapeutics 2018, 40:1448-1456.
• High potency synthetic opioids: Curbing the third wave of the opioid crisis.Parida S, Sofuoglu M. High potency synthetic opioids: Curbing the third wave of the opioid crisis. Neuroscience And Biobehavioral Reviews 2019, 106:9-10.
• Feasibility and effects of galantamine on cognition in humans with cannabis use disorder.Sugarman DE, De Aquino JP, Poling J, Sofuoglu M. Feasibility and effects of galantamine on cognition in humans with cannabis use disorder. Pharmacology, Biochemistry, And Behavior 2019, 181:86-92.
• Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.De Aquino JP, Fairgrieve C, Klaire S, Garcia-Vassallo G. Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting. Journal Of Addiction Medicine 2020.
• Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.Ranganathan M, De Aquino JP, Cortes-Briones JA, Radhakrishnan R, Pittman B, Bhakta S, D'Souza DC. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Psychopharmacology 2019, 236:3209-3219.
• Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.Gupta S, De Aquino JP, D'Souza DC, Ranganathan M. Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis. Psychopharmacology 2019, 236:2635-2640.
• Enhancement of Medical Student Attitudes in the Treatment of Patients with Substance Use Disorders: a Follow-up Study.De Aquino JP, Moore DT, Wilkins K, Fuehrlein B. Enhancement of Medical Student Attitudes in the Treatment of Patients with Substance Use Disorders: a Follow-up Study. Academic Psychiatry : The Journal Of The American Association Of Directors Of Psychiatric Residency Training And The Association For Academic Psychiatry 2019, 43:350-351.
• Kraepelin's Crumbling Twin Pillars: Using Biology to Reconstruct Psychiatric Nosology From the Bottom Up.De Aquino JP, Ross DA. Kraepelin's Crumbling Twin Pillars: Using Biology to Reconstruct Psychiatric Nosology From the Bottom Up. Biological Psychiatry 2017, 82:e71-e74.
• Conflicting evidence: what's a clinician to do?de Aquino Lima JP, Brophy JM. Conflicting evidence: what's a clinician to do? Annals Of Internal Medicine 2010, 153:413-5.
• Case report: Increasing the frequency of intramuscular naltrexone administration in a high risk patient with opioid use disorder.Wright M, De Aquino JP, Bystrak T. Case report: Increasing the frequency of intramuscular naltrexone administration in a high risk patient with opioid use disorder. Substance Abuse : Official Publication Of The Association For Medical Education And Research In Substance Abuse 2021, 1-7.
• Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gómez O, Sofuoglu M. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies. Drug And Alcohol Dependence 2021, 228:109097.
• Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence.De Aquino JP, Parida S, Sofuoglu M. Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence. Clinical Drug Investigation 2021, 41:665.